跳至主要内容
临床试验/NCT04483453
NCT04483453已完成不适用

Effect of Nutritional Intervention on Metabolic Response in Infants: A Single-Blind, Randomized, Controlled Trial

Société des Produits Nestlé (SPN)2 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2020年7月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
102
试验地点
2
主要终点
Glucose peak

研究概览

简要总结

The purpose of this study is to determine the glucose response of complementary feeding regimens consisting of two different follow-up formulas (FUFs) and infant cereals (ICs).

详细描述

This is a prospective, randomized, single-blind, controlled, 2-arm parallel group trial in infants aged 6 months (26 weeks) at enrollment, who are no longer breastfed, and who are ready but have not yet started complementary feeding. They will be fed one of two different isocaloric feeding regimens (Experimental [EXPL] or Control [CTRL]) consisting of different follow-up formulas (FUFs) and infant cereals (ICs). The main purpose of this study is to determine the glucose response of these two different complementary feeding regimens. All enrolled infants will participate in the trial for approximately 6 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Investigator)

入排标准

年龄范围
24 Weeks 至 26 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Written informed consent has been obtained from both parent / liable parent or legally acceptable representative (LAR), if applicable
  • Healthy infant who was singleton, full-term gestational birth (≥ 37 completed weeks of gestation) with a birth weight of ≥ 2.5 kg and ≤ 4.5 kg
  • Infant is no longer breastfeeding or receiving breast milk, has not yet started FUF, and is developmentally ready to begin complementary feeding
  • Infant's parent(s)/guardian is of legal age of consent, must understand the informed consent form and other study documents, and is willing and able to fulfill the requirements of the study protocol.
  • At screening visit (visit 0), infant is 24 - 26 weeks (5½ - 6 months) old
  • Weight-for-height value >-2 standard deviations from the WHO Child Growth Standards median

排除标准

  • Chronic infectious, metabolic, or other disease including any condition that in the opinion of the investigator may impact feeding, growth or adherence to study procedures
  • Major congenital or chromosomal abnormality known to affect growth (e.g., congenital heart disease, cystic fibrosis)
  • Known or suspected cows' milk protein intolerance / allergy, or lactose intolerance, gluten sensitivity or severe food allergies that impact diet
  • Born to mothers with gestational diabetes or type 1 diabetes
  • Major medical/surgical event requiring prolonged hospitalization during the first 6 months
  • Receiving or having received insulin, growth hormone or any other medication known to affect glucose or carbohydrate metabolism or pre- or probiotics known to affect fecal microbiota prior to enrollment
  • Subjects or subjects' parent(s) or legal representative who are not willing and not able to comply with scheduled visits and the requirements of the study protocol
  • Currently participating or having participated in another clinical trial within 4 weeks prior to trial start

结局指标

主要结局

Glucose peak

时间窗: Study days 85-92

Average of the glucose peaks measured by a continuous glucose monitor

次要结局

  • Insulin secretion(age 6 months, 9 months, and 12 months)
  • Dietary intake(age 6 months, 9 months, and 12 months)
  • Stool microbiota composition(age 6 months, 7.5 months, 9 months, and 12 months)
  • Body mass index (BMI)(age 6 months, 9 months, and 12 months)
  • Weight-for-age z-score(age 6 months, 9 months, and 12 months)
  • Weight-for-length z-score(age 6 months, 9 months, and 12 months)
  • Head circumference-for-age z-score(age 6 months, 9 months, and 12 months)
  • Stool microbiota metabolism(age 6 months, 7.5 months, 9 months, and 12 months)
  • Glucose response variability(Study days 85-92)
  • Weight(age 6 months, 9 months, and 12 months)
  • Length-for-age z-score(age 6 months, 9 months, and 12 months)
  • BMI-for-age z-score(age 6 months, 9 months, and 12 months)
  • Length(age 6 months, 9 months, and 12 months)
  • Stool pH(age 6 months, 7.5 months, 9 months, and 12 months)
  • Health-related quality of life(age 6 months, 9 months, and 12 months)
  • Glycemic response(Study days 85-92)
  • Skinfold thickness(age 6 months, 9 months, and 12 months)
  • Head circumference(age 6 months, 9 months, and 12 months)
  • Gastrointestinal (GI) tolerance(age 6 months, 9 months, and 12 months)

研究者

发起方
Société des Produits Nestlé (SPN)
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验